[Specific aspects of treatment for women with bipolar affliction].
This manuscript summarizes specific issues in the disease course and pharmacological treatment of women with bipolar disorders. Gender differences relevant to the female biology manifest in symptoms, outcome, and course. The preponderance of depressive symptoms is typical, and the risk of rapid cycling is estimated to be eight times higher for women than for men. Comorbid anxiety and eating disorders occur more frequently in female patients. In planning treatment it is important to take fertility, contraception, and pregnancy into consideration and adjust the pharmacotherapy to harmonize with the patient's current phase of life. Little is known about potential sexual dysfunctions of bipolar women. Further research should include clinical and observational studies focusing on gender-specific differences in symptomatology, treatment, and long-term outcome of bipolar disorders.
Sasse
J
J
Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Carl Gustav Carus, Technische Universität, Fetscherstrasse 74, 01307, Dresden, Deutschland.
Pilhatsch
M
M
Forsthoff
A
A
Grunze
H
H
Neutze
J
J
Pfennig
A
A
Schmitz
B
B
Schwenkhagen
A
A
Bauer
M
M
D000928:Antidepressive Agents / Q000008:administration & dosage*; D001007:Anxiety / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D001714:Bipolar Disorder / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D003863:Depression / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D005260:Female; D005858:Germany; D006801:Humans; D016387:Women's Health
D000928:Antidepressive Agents